Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
06/20/2000 | CA1341036C Achiral fluorine-containing liquid crystals |
06/17/2000 | CA2292246A1 New hydrazide derivatives, the procedure for preparing them and the pharmaceutical formulations that contain them |
06/15/2000 | WO2000034269A1 Thiourea inhibitors of herpes viruses |
06/15/2000 | WO2000034268A1 Thiourea inhibitors of herpes viruses |
06/15/2000 | WO2000034254A1 Novel compounds |
06/15/2000 | WO2000034237A2 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
06/15/2000 | WO2000034230A1 4-3-substituted-amino-cyclobut-3-ene-1,2-diones and use for influencing smooth muscle contraction |
06/15/2000 | WO2000006531A3 Nitric esters and nitrate salts of specific drugs |
06/15/2000 | DE19857352A1 Ferroelektrische Aktivmatrix-Displays mit weitem Arbeitstemperaturbereich A ferroelectric active matrix display with wide operating temperature range |
06/15/2000 | CA2351390A1 Thiourea inhibitors of herpes viruses |
06/15/2000 | CA2350996A1 Thiourea inhibitors of herpes viruses |
06/15/2000 | CA2350899A1 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
06/15/2000 | CA2350888A1 4-3-substituted-amino-cyclobut-3-ene-1,2-diones and use for influencing smooth muscle contraction |
06/14/2000 | EP1008592A2 Cyclic amide derivatives which inhibit cathepsin K |
06/14/2000 | EP1008346A1 NF-$g(k)B INHIBITORS CONTAINING AS THE ACTIVE INGREDIENT PHENYLMETHYL BENZOQUINONE |
06/14/2000 | EP1008147A2 Ionic liquids as solvents |
06/14/2000 | EP1007521A1 Compounds possessing neuronal activity |
06/14/2000 | EP1007520A1 2-aminopyridines containing fused ring substituents as nos inhibitors |
06/14/2000 | EP1007512A1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors |
06/14/2000 | EP1007033A1 Lymphocyte function antigen-1 antagonists |
06/14/2000 | EP1007032A1 4-cyano-4-deformylsordaricin derivatives |
06/14/2000 | EP1007026A1 Integrin antagonists |
06/14/2000 | EP1007025A1 Use of hydroxyguanidines |
06/14/2000 | EP1007011A1 Lock and key micelles |
06/14/2000 | EP1006793A1 Anti-arrhythmic composition and methods of treatment |
06/14/2000 | EP0777645B1 Oxime ethers and their use as pesticides |
06/14/2000 | CN1256688A Process for synthesis of ribonucleotide reductase inhibitors 3-AP and 3-AMP |
06/14/2000 | CN1256687A Prodrug forms of ribonucleotide reductase inhibitors 3-AP and 3-AMP |
06/14/2000 | CN1256276A Intermediate of beta 3-adrenalin energy receptor protagonist and its synthesis method |
06/14/2000 | CN1256267A Preparation of pyridine propane sultones |
06/13/2000 | US6075148 Carbamates and crop protection agents containing them |
06/13/2000 | US6075126 Phenyldiboronic acid reagents and complexes |
06/13/2000 | US6075055 Excellent fungicidal activities with regard to rice blast and the like, while at the same time do not hinder desirable plant growth |
06/13/2000 | US6075041 Cyclic amides |
06/13/2000 | CA2085878C Bis-benzo or benzopyrido cyclo hepta piperidene, piperidylidene and piperazine compounds and compositions |
06/13/2000 | CA1341023C Peptide derivatives |
06/08/2000 | WO2000032582A1 Benzamide derivatives and their use as apob-100 secretion inhibitors |
06/08/2000 | WO2000032575A1 β-ALANINE DERIVATIVES AS α4 INTEGRIN INHIBITORS |
06/08/2000 | WO2000032574A1 Novel 2-pyridone derivatives, preparation method and therapeutic use |
06/08/2000 | WO2000032573A1 A meta-nitro phenol derivative and a process for producing it |
06/08/2000 | WO2000032570A1 Hydrazine derivatives |
06/08/2000 | WO2000032563A1 Substituted oximes |
06/08/2000 | WO2000032197A1 Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases |
06/08/2000 | DE19855810A1 Substituierte Oxime Substituted oximes |
06/08/2000 | CA2353394A1 Benzamide derivatives and their use as apob-100 secretion inhibitors |
06/08/2000 | CA2351321A1 Hydrazine derivatives |
06/08/2000 | CA2347701A1 .beta.-alanine derivatives as .alpha.4 integrin inhibitors |
06/07/2000 | EP1006135A1 Conjugated N-fluoropyridinium salt-containing polymer and use of the same |
06/07/2000 | EP1006108A1 3-Hydroxy-2(1H)-pyridinone or 3-hydroxy-4(1H)-pyridinone derivatives useful as reactive oxygen species (ROS) scavengers |
06/07/2000 | EP1006107A2 Phthalamide derivatives, or salt thereof agrohorticultural insecticide, and method for using the same |
06/07/2000 | EP1005493A1 Antiviral protease inhibitors |
06/07/2000 | EP1005465A2 New epothilone derivatives, method for producing same and their pharmaceutical use |
06/07/2000 | EP1005457A1 Preparation of pyridine derivatives |
06/07/2000 | EP1005456A1 Method for producing organic compounds |
06/07/2000 | EP1005455A1 Method for producing substituted-2-nitroguanidine derivatives |
06/07/2000 | EP1005446A1 N-aroylphenylalanine derivatives |
06/07/2000 | EP1005445A1 N-alkanoylphenylalanine derivatives |
06/07/2000 | CN1255491A Butyl benzene orthobenzol diacid amide derivative or its salt, garderning pesticide and its application method |
06/07/2000 | CN1053188C Quinolizinone type compounds |
06/07/2000 | CN1053182C Novel 9-amino-7-substituted-6-demethyl-6-deoxytetracyclines, its prepn. process and compsns. thereof |
06/06/2000 | US6071970 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
06/06/2000 | US6071940 Synergistic mixtures with tebuconazole |
06/06/2000 | US6071936 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
06/06/2000 | US6071930 Method for treating tumors using 2-aryl-naphthyridin-4-ones |
06/06/2000 | US6071923 Retinoyloxy aryl-substituted alkylene butyrates useful for the treatment of cancer and other proliferative diseases |
06/06/2000 | US6071920 Bind to 5ht 1a receptors for treating disorders of the lower urinary tract; cns disorders; anxiolytic agents; antidepressants; hypotensive agents; sleep and eating disorders |
06/06/2000 | US6071912 Inhibit human factor xa and are therefore useful as pharmacological agents for the treatment of disease-states characterized by thrombotic activity; amino-, oxy- and thia-substituted triazines |
06/06/2000 | US6071911 4-amino-1-arylpyridin-2-ones and process for making |
06/06/2000 | US6071906 Inhibits or modulates the inducible isoform of nitric oxide synthase over the the constitutive isoforms; antiarthritic, -diabetic, ischemic, thrombosis agents; cardiovascular disorders; toxic shock syndrome; autoimmune diseases |
06/06/2000 | US6071895 Polar-substituted hydrocarbons |
06/06/2000 | US6071861 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production |
06/06/2000 | US6071632 Static lanthanide complexes |
06/06/2000 | US6071510 Modified amino acids and compositions comprising the same for delivering active agents |
06/06/2000 | CA2015033C Tertiary alkyl functionalized piperazine derivatives |
06/02/2000 | WO2000031072A1 Process for making 5-substituted pyrazoles using dithietanes |
06/02/2000 | WO2000031062A1 Cycloalkyl-substituted aminomethylpyrrolidine derivatives |
06/02/2000 | WO2000031036A1 Novel naphthalene derivatives |
06/02/2000 | WO2000031021A1 β-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS |
06/02/2000 | WO2000030589A2 Synthesis of intermediates useful in preparing tricyclic compounds |
06/02/2000 | CA2351692A1 Inhibitors of production and/or secretion of amyloid-.beta. protein |
06/02/2000 | CA2351497A1 Cycloalkyl-substituted aminomethylpyrrolidine derivative |
06/02/2000 | CA2350081A1 Process for making 5-substituted pyrazoles using dithietanes |
05/31/2000 | EP1004581A2 Process for the preparation of thalidomide |
05/31/2000 | EP1004580A2 Imides as inhibitors of TNF alpha |
05/31/2000 | EP1004573A1 Aryloxyaniline derivatives |
05/31/2000 | EP1004572A2 Amines as inhibitors of TNF alpha |
05/31/2000 | EP1003736A1 Substituted 4-benzoyl-pyrazoles |
05/31/2000 | EP1003722A1 Crystalline 10,10-bis((2-fluoro-4-pyridinyl)methyl)-9(10h)-anthracenone and an improved process for preparing the same |
05/31/2000 | EP1003719A2 Microbicidal n-sulfonylglycin alkynyloxyphenemethyl amide derivatives |
05/31/2000 | EP1003712A1 Anthranilic acid analogs |
05/31/2000 | EP1003540A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
05/31/2000 | EP1003495A1 Pharmaceutical compounds |
05/31/2000 | EP0862549B1 Process for preparing optically active carboxylic acids |
05/31/2000 | EP0794942B1 Substituted biphenyl compounds for the treatment of inflammation |
05/31/2000 | EP0633775B1 Compounds useful for treating inflammatory diseases and for inhibiting production of tumor necrosis factor |
05/31/2000 | CN1255123A Process for covalently coupling organic compounds utilizing diboron derivatives |
05/31/2000 | CN1255119A Protease inhibitors |
05/31/2000 | CN1254596A Process for preparing composition to kill internal parasites |
05/30/2000 | US6069254 Carboxamide derivatives of piperidine for the treatment of thrombosis disorders |
05/30/2000 | US6069158 10,11-dihydro-3(3-(4-amino-2-pyridylamino)-1-propyloxy)-5h-dib enzo(a,d)cycloheptene-10-acetic acid |